Brad G Kurowski1, Barynia Backeljauw, Huaiyu Zang, Nanhua Zhang, Lisa J Martin, Valentina Pilipenko, Keith Yeates, H Gerry Taylor, Shari Wade. 1. Divisions of Physical Medicine and Rehabilitation (Drs Kurowski and Wade and Ms Backeljauw), Biostatistics and Epidemiology (Mr H. Zang and Dr N. Zhang), and Human Genetics (Drs Martin and Pilipenko), Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio; and Department of Psychology, University of Calgary, Calgary, Alberta, Canada (Dr Yeates); and Division of Developmental and Behavioral Pediatrics and Psychology, Department of Pediatrics, Case Western Reserve University and Rainbow Babies and Children's Hospital, University Hospitals Case Medical Center, Cleveland, Ohio (Dr Taylor).
Abstract
OBJECTIVE: To elucidate the association of a functional catechol-O-methyltransferase (COMT) genotype (rs4680) with recovery of executive functions up to 18 months after early childhood traumatic brain injury (TBI) compared with an orthopedic injury (OI) group. SETTING: Outpatient. PARTICIPANTS: A total of 134 children with a moderate to severe TBI (n = 63) or OI (n = 71) between the ages of 3 and 6 years who were followed 18 months postinjury. DESIGN: Case-comparison, longitudinal cohort MAIN MEASURES: : The Behavior Rating Inventory of Executive Function, developmental NEuroPSYchological Assessment (NEPSY) of Verbal Fluency, and a modified Stroop Test for young children (Shape School). RESULTS: The low-activity COMT enzyme genotype (AA) was associated with better scores on the developmental NEPSY of Verbal Fluency (F = 3.80; P = .02) and the Shape School (F = 2.89; P = .06) in all participants when controlling for injury type (TBI vs OI) over the first 18 months after injury. Injury type (TBI vs OI) did not significantly moderate the effect of the COMT genotypes on executive function recovery. CONCLUSION: This study provides preliminary evidence for a role of COMT genotypes in long-term recovery of executive function after pediatric TBI and OI. Larger studies are needed to determine the exact link between genetic variation in the COMT gene and TBI recovery in children.
OBJECTIVE: To elucidate the association of a functional catechol-O-methyltransferase (COMT) genotype (rs4680) with recovery of executive functions up to 18 months after early childhood traumatic brain injury (TBI) compared with an orthopedic injury (OI) group. SETTING:Outpatient. PARTICIPANTS: A total of 134 children with a moderate to severe TBI (n = 63) or OI (n = 71) between the ages of 3 and 6 years who were followed 18 months postinjury. DESIGN: Case-comparison, longitudinal cohort MAIN MEASURES: : The Behavior Rating Inventory of Executive Function, developmental NEuroPSYchological Assessment (NEPSY) of Verbal Fluency, and a modified Stroop Test for young children (Shape School). RESULTS: The low-activity COMT enzyme genotype (AA) was associated with better scores on the developmental NEPSY of Verbal Fluency (F = 3.80; P = .02) and the Shape School (F = 2.89; P = .06) in all participants when controlling for injury type (TBI vs OI) over the first 18 months after injury. Injury type (TBI vs OI) did not significantly moderate the effect of the COMT genotypes on executive function recovery. CONCLUSION: This study provides preliminary evidence for a role of COMT genotypes in long-term recovery of executive function after pediatric TBI and OI. Larger studies are needed to determine the exact link between genetic variation in the COMT gene and TBI recovery in children.
Authors: Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger Journal: Proc Natl Acad Sci U S A Date: 2003-04-25 Impact factor: 11.205
Authors: Jeffrey E Max; Amy E Lansing; Sharon L Koele; Carlos S Castillo; Hirokazu Bokura; Russell Schachar; Nicole Collings; Kathryn E Williams Journal: Dev Neuropsychol Date: 2004 Impact factor: 2.253
Authors: John Fossella; Tobias Sommer; Jin Fan; Yanhong Wu; James M Swanson; Donald W Pfaff; Michael I Posner Journal: BMC Neurosci Date: 2002-10-04 Impact factor: 3.288
Authors: Solomon M Adams; Yvette P Conley; Amy K Wagner; Ruchira M Jha; Robert Sb Clark; Samuel M Poloyac; Patrick M Kochanek; Philip E Empey Journal: Pharmacogenomics Date: 2017-10-04 Impact factor: 2.533
Authors: Christine L Petranovich; Julia Smith-Paine; Shari L Wade; Keith Owen Yeates; H Gerry Taylor; Terry Stancin; Brad G Kurowski Journal: J Head Trauma Rehabil Date: 2020 May/Jun Impact factor: 3.117
Authors: Julia Smith-Paine; Allison P Fisher; Shari L Wade; Nanhua Zhang; Huaiyu Zang; Lisa J Martin; Keith Owen Yeates; H Gerry Taylor; Brad G Kurowski Journal: J Head Trauma Rehabil Date: 2020 Jul/Aug Impact factor: 3.117